The pharmaceutical industry is witnessing a significant shift in diabetes treatment with the introduction of GLP-1 patches. These revolutionary delivery systems offer a possibly simple alternative to needle injections for individuals managing diabetes mellitus type 2. By bypassing the necessity for frequent injections, GLP-1 patches promise to boos